SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $189,000 | +2.7% | 1,176 | -37.3% | 0.00% | 0.0% |
| Q1 2020 | $184,000 | -24.3% | 1,876 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $243,000 | +71.1% | 1,876 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $142,000 | -50.3% | 1,876 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $286,000 | +27.7% | 1,876 | 0.0% | 0.00% | +50.0% |
| Q1 2019 | $224,000 | +8.7% | 1,876 | -0.3% | 0.00% | -33.3% |
| Q4 2018 | $206,000 | -32.2% | 1,881 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $304,000 | +22.1% | 1,881 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $249,000 | +26.4% | 1,881 | -29.4% | 0.00% | 0.0% |
| Q1 2018 | $197,000 | +33.1% | 2,664 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $148,000 | +25.4% | 2,664 | +2.5% | 0.00% | 0.0% |
| Q3 2017 | $118,000 | +34.1% | 2,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $88,000 | +8700.0% | 2,600 | +32400.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 8 | +14.3% | 0.00% | – |
| Q4 2015 | $1,000 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |